Beijing Northland Biotech. Co., Ltd.
Quick facts
Phase 3 pipeline
- NL003 · Oncology
NL003 is a recombinant human IL-2 mutein that selectively activates IL-2 receptor signaling to enhance immune cell proliferation and anti-tumor activity. - NL201 · Diabetes
NL201 is a small molecule that targets the SGLT2 receptor.
Phase 2 pipeline
Phase 1 pipeline
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: